Prime Medicine launches $125 million stock offering, details Wilson disease and AATD progressNov 10FinancingPrime Medicine, Inc.Updated
Prime Medicine clears path for two liver programs, gains RMAT for PM359Aug 6Quarterly updatePrime Medicine, Inc.
Prime Medicine registers Phase 1/2 trial of PM577a prime editing therapy for Wilson diseaseAug 5Trial updatePM577APrime Medicine, Inc.